NO20021476D0 - Farmasöytisk b¶rerformulering - Google Patents

Farmasöytisk b¶rerformulering

Info

Publication number
NO20021476D0
NO20021476D0 NO20021476A NO20021476A NO20021476D0 NO 20021476 D0 NO20021476 D0 NO 20021476D0 NO 20021476 A NO20021476 A NO 20021476A NO 20021476 A NO20021476 A NO 20021476A NO 20021476 D0 NO20021476 D0 NO 20021476D0
Authority
NO
Norway
Prior art keywords
borer
formulation
pharmaceutical
pharmaceutical borer
borer formulation
Prior art date
Application number
NO20021476A
Other languages
English (en)
Other versions
NO20021476L (no
Inventor
Joseph Kyuwung Yoon
Richard William Saunders
Mahdi Bakir Fawzi
Original Assignee
American Cyanamid Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Cyanamid Co filed Critical American Cyanamid Co
Publication of NO20021476D0 publication Critical patent/NO20021476D0/no
Publication of NO20021476L publication Critical patent/NO20021476L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO20021476A 1999-09-27 2002-03-25 Farmasöytisk b¶rerformulering NO20021476L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US40616499A 1999-09-27 1999-09-27
PCT/US2000/026381 WO2001022942A1 (en) 1999-09-27 2000-09-26 Pharmaceutical carrier formulation

Publications (2)

Publication Number Publication Date
NO20021476D0 true NO20021476D0 (no) 2002-03-25
NO20021476L NO20021476L (no) 2002-04-16

Family

ID=23606801

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20021476A NO20021476L (no) 1999-09-27 2002-03-25 Farmasöytisk b¶rerformulering

Country Status (18)

Country Link
EP (1) EP1216029A1 (no)
JP (1) JP2003510267A (no)
KR (1) KR20020064289A (no)
CN (1) CN1399542A (no)
AR (1) AR025867A1 (no)
AU (1) AU7716100A (no)
BR (1) BR0014308A (no)
CA (1) CA2388471A1 (no)
CZ (1) CZ20021082A3 (no)
EA (1) EA200200415A1 (no)
HK (1) HK1044485A1 (no)
HU (1) HUP0202652A3 (no)
IL (1) IL148543A0 (no)
MX (1) MXPA02003190A (no)
NO (1) NO20021476L (no)
PL (1) PL354331A1 (no)
WO (1) WO2001022942A1 (no)
ZA (1) ZA200203311B (no)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7138393B2 (en) 1998-07-24 2006-11-21 Wyeth Biologically active vasopressin agonist metabolites
US20030105144A1 (en) * 2001-04-17 2003-06-05 Ping Gao Stabilized oral pharmaceutical composition
JPWO2004073692A1 (ja) * 2003-02-18 2006-06-01 山下　伸二 難水溶性薬物のハードカプセル剤
CN100342856C (zh) * 2003-04-10 2007-10-17 上海医药工业研究院 达那唑半固体骨架制剂的组合物
CA2627292C (en) * 2005-10-26 2012-04-17 Banner Pharmacaps, Inc. Hydrophilic vehicle-based dual controlled release matrix system
CN101351196B (zh) 2005-10-26 2013-07-03 班纳制药公司 作为胶囊填充物的基于亲脂性载体的双重控释基质系统
BRPI0718042A2 (pt) * 2006-10-31 2013-11-12 Wyeth Corp Formulações semissólidas de inibidores de enzima fosfolipase
US11389383B2 (en) * 2017-12-20 2022-07-19 Firmenich Sa Oral care compositions
EP3733826B1 (en) * 2019-05-03 2024-07-17 The Procter & Gamble Company Particle treatment compositions comprising an antioxidant
CN119343137A (zh) * 2022-06-13 2025-01-21 R·P·谢勒技术有限公司 肠溶比沙可啶软凝胶胶囊

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3636123A1 (de) * 1986-10-23 1988-05-05 Rentschler Arzneimittel Arzneizubereitungen zur oralen verabreichung, die als einzeldosis 10 bis 240 mg dihydropyridin enthalten
WO1995022331A1 (en) * 1994-02-18 1995-08-24 Cephalon, Inc. Aqueous indolocarbazole solutions
ATE429210T1 (de) * 1998-01-20 2009-05-15 Applied Analytical Ind Inc Orale flüssige zusammensetzungen

Also Published As

Publication number Publication date
AU7716100A (en) 2001-04-30
HUP0202652A2 (hu) 2004-05-28
HUP0202652A3 (en) 2004-06-28
NO20021476L (no) 2002-04-16
KR20020064289A (ko) 2002-08-07
ZA200203311B (en) 2003-12-31
EA200200415A1 (ru) 2002-10-31
HK1044485A1 (zh) 2002-10-25
IL148543A0 (en) 2002-09-12
WO2001022942A1 (en) 2001-04-05
JP2003510267A (ja) 2003-03-18
CN1399542A (zh) 2003-02-26
EP1216029A1 (en) 2002-06-26
CZ20021082A3 (cs) 2002-06-12
CA2388471A1 (en) 2001-04-05
BR0014308A (pt) 2002-05-21
MXPA02003190A (es) 2002-09-30
PL354331A1 (en) 2004-01-12
AR025867A1 (es) 2002-12-18

Similar Documents

Publication Publication Date Title
FIU20000164U0 (fi) Uusi farmaseuttinen formulaatio
DK1189853T3 (da) Betonformulering
ITTO20010008A0 (it) Formulazione farmaceutica
ATE392890T1 (de) Hydrogel-gesteuerte dosierungsform
IS6310A (is) Kínasólínafleiður til lækninga
ATE352339T1 (de) Medikamentspender
FI991485L (fi) Uusi farmaseuttinen koostumus
NO20012915D0 (no) Ny farmasöytisk formulering
NO992339D0 (no) Farmas°ytiske formuleringer
NO20020086D0 (no) Smaksmaskerte farmasöytiske flytende formuleringer
NO20022692D0 (no) Terapeutiske midler
NO20015670L (no) Forbedrede farmasöytiske formuleringer
PT1210085E (pt) Solucoes farmaceuticas de levosimendano
NO20022606L (no) Farmasöytiske kombinasjoner
DK1275397T3 (da) Lægemiddel til lokal anvendelse
NO20014926D0 (no) Farmasöytiske forbindelser
NO20021476D0 (no) Farmasöytisk b¶rerformulering
ID30032A (id) Formulasi farmasi
EE200100697A (et) Farmatseutiline kompleks
NO20004816D0 (no) Ny farmasøytisk formulering
NO20016301D0 (no) Terapeutiske midler
SE9902902D0 (sv) New formulation
SE9803952D0 (sv) Pharmaceutical formulation
SE9901967D0 (sv) New solid dosage formulation
SK2484U (sk) Závorový adaptér

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application